Skip to content

Study on the Evaluation of the Effect of Precise Diagnosis and Treatment of Endemic Fluorosis: A Cluster-Randomized Controlled Trial

Study on Screening of Effective Treatment Drugs and Evaluation of Diagnosis and Treatment Effect of Fluorosis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075706
Enrollment
Unknown
Registered
2023-09-13
Start date
2023-09-15
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fluorosisofbone

Interventions

Ginkgo biloba & Epimedium groups:Ginkgo biloba and Epimedium three times a day for three months.
Xianlingbao & Cortex Eucommia groups:Xianlingba and Cortex Eucommia three times a day for three months.
Osteoporosis & Prickly Pear Groups:Osteoporosis and Prickly Pear three times a day for three months.

Sponsors

Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Residents aged 40~years old, with the same place of residence and place of origin; 2. Voluntarily participating in the project, agreeing to collect biological samples and signing an informed consent form; 3. Free of mental and other related diseases, with normal expression and comprehension; 4. Combined with the diagnostic standard of endemic fluorosis in WS/T 192-2021, the patients can be diagnosed as patients with endemic fluorosis.

Exclusion criteria

Exclusion criteria: 1. Those who have received interventions and treatments with other drugs related to the treatment of fluorosis in the country; 2. Those who have abnormalities in liver and kidney functions in routine blood tests.

Design outcomes

Primary

MeasureTime frame
X-ray Signs of Fluorosis;

Secondary

MeasureTime frame
Physical Functioning;Bodily Pain;Mini-mental State Examination,MMSE;Assessment of Joint Mobility Measurement;

Countries

China

Contacts

Public ContactLUO PENG

Guizhou Medical University

luopeng@gmc.edu.cn+86 139 8414 3826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026